메뉴 건너뛰기




Volumn , Issue 29, 2008, Pages 8-10

Tough choices: Tenofovir, tenders and treatment

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; DIDANOSINE; EFAVIRENZ; EFAVIRENZ PLUS EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; EMTRICITABINE; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; GENERIC DRUG; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; NEVIRAPINE; STAVUDINE; TENOFOVIR DISOPROXIL; ZALCITABINE; ZIDOVUDINE;

EID: 44649139747     PISSN: 16089693     EISSN: None     Source Type: Journal    
DOI: 10.4102/sajhivmed.v9i1.658     Document Type: Article
Times cited : (10)

References (16)
  • 1
    • 38849194560 scopus 로고    scopus 로고
    • Chien CV. HIV/AIDS drugs for Sub-Saharan Africa: how do brand and generic supply compare? PLoS ONE 2007; 2(3): e278.
    • Chien CV. HIV/AIDS drugs for Sub-Saharan Africa: how do brand and generic supply compare? PLoS ONE 2007; 2(3): e278.
  • 2
    • 33748362446 scopus 로고    scopus 로고
    • How do intellectual property law and international trade agreements affect access to antiretroviral therapy?
    • Westerhaus M, Castro A. How do intellectual property law and international trade agreements affect access to antiretroviral therapy? PLoS Med 2006; 8: 1230-1236.
    • (2006) PLoS Med , vol.8 , pp. 1230-1236
    • Westerhaus, M.1    Castro, A.2
  • 3
    • 0035904286 scopus 로고    scopus 로고
    • Do patents for antiretroviral drugs constrain access to AIDS treatment in Africa?
    • Attaran A, Gillespie-White L. Do patents for antiretroviral drugs constrain access to AIDS treatment in Africa? JAMA 2001; 286(15): 1886-1892.
    • (2001) JAMA , vol.286 , Issue.15 , pp. 1886-1892
    • Attaran, A.1    Gillespie-White, L.2
  • 5
    • 35448949523 scopus 로고    scopus 로고
    • Leveraging university research to advance global health
    • Chokshi D, Rajkumar R. Leveraging university research to advance global health. JAMA 2007; 298: 1934-1936.
    • (2007) JAMA , vol.298 , pp. 1934-1936
    • Chokshi, D.1    Rajkumar, R.2
  • 6
    • 1242317747 scopus 로고    scopus 로고
    • The role of civil society in protecting public health over commercial interests: Lessons from Thailand
    • Ford N, Wilson D, Bunjumnong O, von Schoen-Angerer T. The role of civil society in protecting public health over commercial interests: lessons from Thailand. Lancet 2004; 363: 560-563.
    • (2004) Lancet , vol.363 , pp. 560-563
    • Ford, N.1    Wilson, D.2    Bunjumnong, O.3    von Schoen-Angerer, T.4
  • 7
    • 34447329578 scopus 로고    scopus 로고
    • Sustaining access to antiretroviral therapy in developing countries: Lessons from Brazil and Thailand
    • Ford N, Wilson D, Costa Chaves G, Lotrowska M, Kijtiwatchakul K. Sustaining access to antiretroviral therapy in developing countries: lessons from Brazil and Thailand. AIDS 2007; 21(Suppl 4): S21-S29.
    • (2007) AIDS , vol.21 , Issue.SUPPL. 4
    • Ford, N.1    Wilson, D.2    Costa Chaves, G.3    Lotrowska, M.4    Kijtiwatchakul, K.5
  • 8
    • 33745613513 scopus 로고    scopus 로고
    • Improving access to medicines in poor countries: The role of universities
    • Chokshi D. Improving access to medicines in poor countries: The role of universities. PLOS Med 2006; 6: 723-726.
    • (2006) PLOS Med , vol.6 , pp. 723-726
    • Chokshi, D.1
  • 9
    • 85029293694 scopus 로고    scopus 로고
    • US patent office rejects Gilead Viread patents. Reuters, 23 January 2008
    • Beasley D. US patent office rejects Gilead Viread patents. Reuters, 23 January 2008.
    • Beasley, D.1
  • 11
    • 85029312379 scopus 로고    scopus 로고
    • Gilead Sciences and Aspen Pharmacare sign letter of intent to establish non-exclusive licensing and distribution agreement for antiretrovirals truvada and viread in developing world countries. Business Wire, 25 April 2005, accessed 10 February 2008
    • Gilead Sciences and Aspen Pharmacare sign letter of intent to establish non-exclusive licensing and distribution agreement for antiretrovirals truvada and viread in developing world countries. Business Wire, 25 April 2005. http://findarticles.com/p/articles/mi_mOEIN/ is_2005_April_25/ai_n13650816 (accessed 10 February 2008).
  • 13
    • 85029330157 scopus 로고    scopus 로고
    • Regensberg L, Whitelaw C, eds. Aid for AIDS Guideline. 6th ed. Howard Place: Aid for AIDS, 2007.
    • Regensberg L, Whitelaw C, eds. Aid for AIDS Guideline. 6th ed. Howard Place: Aid for AIDS, 2007.
  • 14
    • 85029329426 scopus 로고    scopus 로고
    • 15th ed. Geneva: World Health Organization
    • Model Essential Medicines List. 15th ed. Geneva: World Health Organization, 2007.
    • (2007) Model Essential Medicines List
  • 15
    • 34547814064 scopus 로고    scopus 로고
    • Substitutions due to antiretroviral toxicity or contraindication in the first 3 years of antiretroviral therapy in a large South African cohort
    • Boulle A, Orrell C, Kaplan R, et al. Substitutions due to antiretroviral toxicity or contraindication in the first 3 years of antiretroviral therapy in a large South African cohort. Antiviral Therapy 2007; 12: 753-760.
    • (2007) Antiviral Therapy , vol.12 , pp. 753-760
    • Boulle, A.1    Orrell, C.2    Kaplan, R.3
  • 16
    • 85029306327 scopus 로고    scopus 로고
    • Request for proposals/quotation. RT71-2004MF. The supply of antiretroviral drugs for the Department of Health's Comprehensive HFV and AIDS Care, Management and Treatment Plan. Pretoria: State Tender Board, 2004.
    • Request for proposals/quotation. RT71-2004MF. The supply of antiretroviral drugs for the Department of Health's Comprehensive HFV and AIDS Care, Management and Treatment Plan. Pretoria: State Tender Board, 2004.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.